Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
Tanvex BioPharma, Inc. (“Tanvex”), a contract development and manufacturing organization
43rd Annual J.P. Morgan Healthcare Conference Bora Pharmaceuticals has been
Bora Biologics Announces Strategic Collaboration to Accelerate Key CMC Development
Bora Pharmaceuticals Announces Unveiling of New Multi-Purpose Small Molecule Site
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
Bora Appoints J.D. Mowery As First Division President Of Its
Tanvex BioPharma, Inc. (“Tanvex” or “the Company”, TWSE: 6541), the
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
